Trial Profile
Monitoring of Expected Parameters of the Application Technique and Safety of the Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2016
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 28 Jan 2012 New trial record